Skip to main content

David Rutledge, PharmD

Original Contribution
09/06/2014
Xience V USA is a prospective multicenter registry evaluating outcomes in patients treated with EES. Here, we present the 12-month clinical outcomes in patients who received EES for the treatment of in-stent restenosis (ISR) and non-ISR.     
Xience V USA is a prospective multicenter registry evaluating outcomes in patients treated with EES. Here, we present the 12-month clinical outcomes in patients who received EES for the treatment of in-stent restenosis (ISR) and non-ISR.     
Xience V USA is a prospective...
09/06/2014
Journal of Invasive Cardiology